Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEAction(s) taken or orders passedRegulatory13 Jul 2026

Kalyani Steels Limited

Action(s) taken or orders passed

Kalyani Steels Limited has received a direction from the Central Pollution Control Board (CPCB) to close operations of its plant located at Hospet Road, Village Ginigera, Talula & District Koppal, Karnataka. The company is directed to submit its compliance within 30 days.

Read more →📎 1 attachment
NSEGeneral UpdatesRegulatory13 Jul 2026

Gujarat Themis Biosyn Limited

General Updates

Gujarat Themis Biosyn Limited has informed the Exchange about General Updates on Arbitration matter, stating that the parties have amicably resolved the disputes and settled the matter mutually, with no material financial impact.

Read more →📎 1 attachment
NSEAction(s) taken or orders passedRegulatory13 Jul 2026

Hariom Pipe Industries Limited

Action(s) taken or orders passed

Hariom Pipe Industries Limited has received proceedings from the Tamil Nadu Pollution Control Board (TNPCB) suspending the earlier closure order and restoring power supply to its Perundurai unit, effective until March 31, 2027.

Read more →📎 1 attachment
NSEUpdatesRegulatory13 Jul 2026

ORTIN GLOBAL LIMITED

Updates

ORTIN GLOBAL LIMITED has submitted a post-offer advertisement under SEBI (SAST) Regulations for the attention of its equity shareholders.

NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Regulatory13 Jul 2026

Kalpataru Limited

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Kalpataru Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming that all shares are in dematerialized mode and no dematerialization/mutilation/cancellation requests were received during the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSEGeneral UpdatesRegulatory13 Jul 2026

Alembic Pharmaceuticals Limited

General Updates

Alembic Pharmaceuticals Limited has received a Warning Letter from the USFDA regarding observations on Informed Consent Form (ICF) in a bioequivalence study. The Company believes the Warning Letter does not impose any restriction on its operations and is coordinating with the Clinical Investigator to submit a response within the stipulated timeline.

Read more →📎 1 attachment